Superiority of Directly Administered Antiretroviral Therapy over Self-Administered Therapy among HIV-Infected Drug Users: A Prospective, Randomized, Controlled Trial
Open accessThe DOI matches its Crossref record.
Abstract
BACKGROUND: Directly administered antiretroviral therapy (DAART) is one approach to improve treatment adherence among human immunodeficiency virus (HIV)-infected drug users. METHODS: In this randomized, controlled trial (ClinicalTrials.gov identifier, NCT00367172), the biological outcomes of a 6-month community intervention of DAART were compared with those of self-administered therapy among HIV-infected drug users. Patients randomized to receive DAART received supervised therapy 5 days per week from workers in a mobile health care van. The primary outcome, using an intention-to-treat approach, was the proportion of patients achieving either a reduction in HIV-1 RNA level of > or = 1.0 log10 copies/mL or an HIV-1 RNA level < or = 400 copies/mL at 6 months. Secondary outcomes included the mean change from baseline in HIV-1 RNA level and CD4+ T lymphocyte count. RESULTS: Of the 141 patients who met the entry criteria, 88 were randomized to receive DAART, and 53 were randomized to receive self-administered therapy; 74 (84%) of 88 of the patients randomized to receive DAART accepted the intervention. Of the 74 patients who initiated DAART, 51 (69%) completed the full 6-month intervention. At the end of 6 months, a significantly greater proportion of the DAART group achieved the primary outcome (70.5% vs. 54.7; P=.02). Additionally, compared with patients receiving self-administered therapy, patients receiving DAART demonstrated a significantly greater mean reduction in HIV-1 RNA level (-1.16 log10 copies/mL vs. -0.29 log10 copies/mL; P=.03) and mean increase in CD4+ T lymphocyte count (+58.8 cells/microL vs. -24.0 cells/microL; P=.002). CONCLUSIONS: This randomized, controlled trial was, to our knowledge, the first to demonstrate the effectiveness of DAART at improving 6-month virologic outcomes among drug users. These results suggest that DAART should be more widely available in HIV treatment programs that target drug users who have poor adherence to treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Thompson, M. A., Mugavero, M. J., Amico, K. R., Cargill, V. A., Chang, L. W., Gross, R., Orrell, C., Altice, F. L., Bangsberg, D. R., Bartlett, J. G., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-11-201206050-00419 · Cited by 582
Self-citationAltice, F. L., Kamarulzaman, A., Soriano, V. V., Schechter, M., & Friedland, G. H. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60829-x · Cited by 504
Self-citationExplaining Adherence Success in Sub-Saharan Africa: An Ethnographic Study
Ware, N. C., Idoko, J., Kaaya, S., Biraro, I. A., Wyatt, M. A., Agbaji, O., Chalamilla, G., & Bangsberg, D. R. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000011 · Cited by 437
Wolfe, D., Carrieri, M. P., & Shepard, D. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60832-x · Cited by 418
Iacob, S. A., Iacob, D. G., & Jugulete, G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00831 · Cited by 265
Springer, S. A., Spaulding, A. C., Meyer, J. P., & Altice, F. L. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir446 · Cited by 192
“Altice et al 2007 [26–28] 141 HIV-positive active drug users; New Haven, CT RCT; DAART provided once-daily, 5 days per week for 6 months.”
BackgroundSelf-citationStrategies for promoting adherence to antiretroviral therapy: A review of the literature
Simoni, J. M., Amico, K. R., Pearson, C. R., & Malow, R. (2008) · Current Infectious Disease Reports · doi:10.1007/s11908-008-0083-y · Cited by 190
“acceptable and feasible across diverse settings and among various populations: substance users [ 39 ,40], persons with a history of poor adherence [41], ART-naive individuals or those changing regimens [42], children and adolescents [43], and others [44–46].”
BackgroundPreventing HIV Antiretroviral Resistance through Better Monitoring of Treatment Adherence
Bangsberg, D. R. (2008) · The Journal of Infectious Diseases · doi:10.1086/533415 · Cited by 183
“These strategies include adherence case management [16-19], couple-based counseling [8], pharmacist-based education [20], telephone support [21], reminder devices [22], home visits by a nurse [23], and directly observed therapy [24-27].”
BackgroundGreen, T. C., Kershaw, T., Lin, H., Heimer, R., Goulet, J. L., Kraemer, K. L., Gordon, A. J., Maisto, S. A., Day, N. L., Bryant, K., et al. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.02.020 · Cited by 101
Metadata
- Authors
- Altice, F. L., Maru, D. S.-R., Bruce, R. D., Springer, S. A., & Friedland, G. H.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-09-15
- Volume
- 45
- Issue
- 6
- Pages
- 770-778
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2160957455
- Cited by
- 156
- References
- 0
- FWCI
- 9.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.